The first stage of preclinical trial of the wave therapy device has been successfully completed.
Preclinical trials took place at the "Institute of experimental pathology, oncology and radiobiology named Kavetskogo R.E." on the base of NAS of Ukraine, Kyiv under the guidance of Professor, S.D., Mosienko V.S..
The objective of the first stage of preclinical trials was to answer the question: does the wave therapy influence cancer body?
The first stage of preclinical trials was conducted on mice, they were subcutaneously inoculated of solid Ehrlich Carcinoma (CMV 5 000 000 cancer cells). Three groups of 6 mice each were involved. Groups were divided into two control ones and one that was exposed to a wave therapy deviсe.
The mice were exposed to from the second day after the inoculation of Ehrlich Carcinoma.
In 7 days and after 4 sessions of wave therapy, at first check in it was observed that in the control groups some mice died: first group - 2 mice , second group - 1 mouse.
There was no dead mice in our group.
As was revealed during the autopsy of the dead animals, worm infestation caused the death.
There were 14 sessions of wave therapy within 21 days in total.
During next control periods was recorded the following: deceleration of tumor "release" for 6 days in the group that was exposed to wave therapy. As well as slowdown of tumor growth up to 35 - 52 %.
The life expectancy in the control group increased up to approx.100%, and in terms of time was 46 days.
It should be noted that the life expectancy of mice in these conditions (inoculation of Ehrlich Carcinoma) ranges from 22 to 25 days.
en.onko-stop.com
Смотрите видео The first stage of preclinical trial of the wave therapy device has been ssuccessfully completed онлайн, длительностью часов минут секунд в хорошем качестве, которое загружено на канал Onko StopCom 26 Ноябрь 2014. Делитесь ссылкой на видео в социальных сетях, чтобы ваши подписчики и друзья так же посмотрели это видео. Данный видеоклип посмотрели 102 раз и оно понравилось like посетителям.